Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India.

Neurology India - 1 Jan 2000

Vijayan Bejoy, Gopala Srinivas, Kishore Asha

Abstract excerpt

BACKGROUND: The frequency of leucine-rich repeat kinase 2 (LRRK2) G2019S mutation, the most common genetic cause of Parkinson's disease (PD), shows significant variation based on ethnicity. Earlier reports suggest a very low frequency or absence of this mutation in Asians. OBJECTIVE: To analyze the frequency of LRRK2 G2019S mutation in sporadic and familial cases of PD and normal controls of common ethnicity from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Gene Frequency
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Haplotypes

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Parkinson Disease

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 21483109
DOI: 10.4103/0028-3886.79125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India.PMID 21483109Read ↗

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.Semantic proximity Read ↗

Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients.Semantic proximity Read ↗

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.Semantic proximity Read ↗

Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.Semantic proximity Read ↗

Evaluation of the Role of LRRK2 Gene in Parkinson’s Disease in an East Indian CohortSemantic proximity Read ↗

Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.Semantic proximity Read ↗

G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.Semantic proximity Read ↗

Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease.Semantic proximity Read ↗

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s DiseaseSemantic proximity Read ↗

The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease.Semantic proximity Read ↗

Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson diseaseSemantic proximity Read ↗

Leucine rich repeat kinase 2 (LRRK2) gly2019ser mutation is absent in a second cohort of nigerian africans with parkinson diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.